Skip to main content
. Author manuscript; available in PMC: 2017 Jan 15.
Published in final edited form as: J Neuroimmunol. 2016 Dec 1;302:10–19. doi: 10.1016/j.jneuroim.2016.11.012

Figure 2A.

Figure 2A

NO2 production in resting and LPS/IFNγ treated C6 glioma cells ± selective iNOS inhibitor: L-NIL (20μg/ml) or hydrocortisone (20μg/ml). The data represent NO2− produced (μM) and are expressed as the Mean ± S. E. M., n=4. Differences between resting and activated cells were determined by a Student’s t-test (*) P<.001, and LPS vs. L-NIL and hydrocortisone treated cells [*].